Clinical Usefulness of the QMAC-dRAST System for AmpC β-lactamase-Producing Enterobacterales
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Rapid antimicrobial susceptibility testing (RAST) is important for theappropriate treatment of bloodstream infections. The QMAC-dRAST system (QuantaMatrixInc., Korea) can directly perform RAST using positive blood culture samples with microscopicimaging. This study aimed to evaluate the performance of the QMAC-dRAST system for AmpC-β-lactamase-producing Enterobacterales. Methods: Eighty isolates (20 Morganella morganii, 20 Serratia marcescens, 10 Klebsiellaaerogenes, 10 Enterobacter cloacae, and 20 Citrobacter freundii) and 14 antimicrobial agentswere included in the antimicrobial susceptibility testing (AST). The performance of theQMAC-dRAST system was evaluated by simulating the clinical blood culturing process. Weconducted a comparative evaluation of the QMAC-dRAST and Vitek 2 systems (bioMérieux Inc.,France). Broth microdilution tests were performed as the reference method to resolve anydiscrepancies in the AST results between the two systems. Results: For 20 M. morganii and 20 S. marcescens, the categorical agreement (CA) betweenthe QMAC-dRAST and Vitek 2 systems increased from 55.4% to 83.8% after AST algorithmoptimization. Moreover, the discrepancy rates decreased as follows: from 19.1% to 5.4% verymajor errors (VME), from 38.3% to 4.3% major errors (ME), and from 14.6% to 12.1% minorerrors (mE) for the QMAC-dRAST system compared to the Vitek 2 system. For all 80 testedisolates, the QMAC-dRAST system showed 93.0% CA, 1.7% VME, 2.3% ME, and 4.9% mE. Conclusion: The QMAC-dRAST system was comparable to the Vitek 2 system after ASTalgorithm optimization for AmpC β-lactamase-producers, which are major pathogens andrequire time to express the enzyme. However, further modifications of the AST algorithm arestill warranted.
Abstract
Background: Rapid antimicrobial susceptibility testing (RAST) is important for theappropriate treatment of bloodstream infections. The QMAC-dRAST system (QuantaMatrixInc., Korea) can directly perform RAST using positive blood culture samples with microscopicimaging. This study aimed to evaluate the performance of the QMAC-dRAST system for AmpC-β-lactamase-producing Enterobacterales. Methods: Eighty isolates (20 Morganella morganii, 20 Serratia marcescens, 10 Klebsiellaaerogenes, 10 Enterobacter cloacae, and 20 Citrobacter freundii) and 14 antimicrobial agentswere included in the antimicrobial susceptibility testing (AST). The performance of theQMAC-dRAST system was evaluated by simulating the clinical blood culturing process. Weconducted a comparative evaluation of the QMAC-dRAST and Vitek 2 systems (bioMérieux Inc.,France). Broth microdilution tests were performed as the reference method to resolve anydiscrepancies in the AST results between the two systems. Results: For 20 M. morganii and 20 S. marcescens, the categorical agreement (CA) betweenthe QMAC-dRAST and Vitek 2 systems increased from 55.4% to 83.8% after AST algorithmoptimization. Moreover, the discrepancy rates decreased as follows: from 19.1% to 5.4% verymajor errors (VME), from 38.3% to 4.3% major errors (ME), and from 14.6% to 12.1% minorerrors (mE) for the QMAC-dRAST system compared to the Vitek 2 system. For all 80 testedisolates, the QMAC-dRAST system showed 93.0% CA, 1.7% VME, 2.3% ME, and 4.9% mE. Conclusion: The QMAC-dRAST system was comparable to the Vitek 2 system after ASTalgorithm optimization for AmpC β-lactamase-producers, which are major pathogens andrequire time to express the enzyme. However, further modifications of the AST algorithm arestill warranted.
참고문헌 (27)
- WHO, "Antimicrobial resistance : global report on surveillance", World Health Organization, ~ (2014)
- Ferri M, "Antimicrobial resistance : a global emerging threat to public health systems", Crit Rev Food Sci Nutr, 57, pp.2857~2876 (2017)
- Schefold JC, "Sepsis : time has come to focus on the later stages", Med Hypotheses, 71, pp.203~208 (2008)
- Ibrahim EH, "The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting", Chest, 118, pp.146~155 (2000)
- Beekmann S, "Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges", J Clin Microbiol, 41, pp.3119~3125 (2003)
- Banerjee R, "Rapid antimicrobial susceptibility testing methods for blood cultures and their clinical impact", Front Med, 8, pp.167~ (2021)
- Jin WY, "Evaluation of VITEK 2, MicroScan, and Phoenix for identification of clinical isolates and reference strains", Diagn Microbiol Infect Dis, 70, pp.442~447 (2011)
- 강다영, "국내에서 분리된 인체분리균주를 이용한 MicroScan KSCM 패널의 항균제 감수성 시험 분석능 평가", Annals of Clinical Microbiology, 22(3), pp.61~70 (2019), 대한임상미생물학회[DOI]
- Inglis TJ, "Rapid antimicrobial susceptibility tests for sepsis; the road ahead", J Med Microbiol, 68, pp.973~977 (2019)
- Choi J, "Direct, rapid antimicrobial susceptibility test from positive blood cultures based on microscopic imaging analysis", Sci Rep, 7, pp.1~13 (2017)
- Kim JH, "Direct rapid antibiotic susceptibility test(dRAST)for blood culture and its potential usefulness in clinical practice", J Med Microbiol, 67, pp.325~331 (2018)
- 김현정, "Clinical Evaluation of QMAC-dRAST for Direct and Rapid Antimicrobial Susceptibility Test with Gram-Positive Cocci from Positive Blood Culture Bottles", Annals of Clinical Microbiology, 21(1), pp.12~19 (2018), 대한임상미생물학회
- Kim JH, "Prospective evaluation of a rapid antimicrobial susceptibility test(QMAC-dRAST)for selecting optimal targeted antibiotics in positive blood culture", J Antimicrob Chemother, 74, pp.2255~2260 (2019)
- Huh HJ, "Performance evaluation of the QMAC-dRAST for staphylococci and enterococci isolated from blood culture : a comparative study of performance with the VITEK-2 system", J Antimicrob Chemother, 73, pp.1267~1271 (2018)
- Grohs P, "Comparative evaluation of the QMAC-dRAST V2.0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates", J Microbiol Methods, 172, pp.105902~ (2020)
- Jacoby GA, "AmpC beta-lactamases", Clin Microbiol Rev, 22, pp.161~182 (2009)
- 정혜숙, "유도 AmpC β-lactamase를 생산하는 장내세균 혈액분리균에서의 extended-spectrum β-lactamase 생성균의 빈도", Infection and Chemotherapy, 42(5), pp.280~284 (2010), 대한감염학회
- Paterson DL, "Resistance in gram-negative bacteria : Enterobacteriaceae", Am J Infect Control, 34, pp.S20~8 (2006)
- Chow JW, "Enterobacter bacteremia : clinical features and emergence of antibiotic resistance during therapy", Ann Intern Med, 115, pp.585~590 (1991)
- Pfaller MA, "Antimicrobial susceptibility of inducible AmpC β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997–2000", Int J Antimicrob Agents, 19, pp.383~388 (2002)
- Park YJ, "Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacter cloacae, Citrobacter freundii , and Serratia marcescens: a Korean survey", Korean J Lab Med, 23, pp.251~257 (2003)
- Clinical and Laboratory Standards Institute (CLSI), "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; CLSI M07", ~ (2018)
- Food and Drug Administration, "Guidance for industry and FDA. Class II special controls guidance document: antimicrobial susceptibility test (AST) systems", Center for Devices and Radiological Health, Food and Drug Administration, US Department of Health and Human Services, ~ (2009)
- Thomson KS, "Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues", J Clin Microbiol, 48, pp.1019~1025 (2010)
- Choi SH, "Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC betalactamase : implications for antibiotic use", Antimicrob Agents Chemother, 52, pp.995~1000 (2008)
- Cosgrove SE, "Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species", Arch Intern Med, 162, pp.185~190 (2002)
- Quesada M, "Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT", ALERT blood culture bottles, 2010, pp.16, 137~140